UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of August 2022

 

Commission File Number: 001-39328

 

 

 

Genetron Holdings Limited

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

1-2/F, Building 11, Zone 1

No.8 Life Science Parkway

Changping District, Beijing, 102206

People’s Republic of China

+86 10 5090-7500

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x      Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Genetron Holdings Limited
     
  By: /s/ Sizhen Wang
  Name: Sizhen Wang
  Title: Chief Executive Officer

 

Date: August 22, 2022

 

 

 

 

EXHIBIT INDEX

 

Exhibit   Description
99.1   Press Release titled “Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company.”

 

 

 

Genetron (NASDAQ:GTH)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Genetron Charts.
Genetron (NASDAQ:GTH)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Genetron Charts.